immunotherapy

February 4, 2016 · Greg Guthrie, ASCO staff
Immunotherapy made exciting strides in 2015. Because of its potential, ASCO named it the 2016 Clinical Cancer Advance of the Year. Read More >>
May 29, 2015 · Amber Bauer, ASCO staff
Immunotherapy is one of the hottest topics in cancer research. This year, focus at the ASCO Annual Meeting has been on a type of immunotherapy called PD-1 inhibitors. Learn how these drugs may help improve the treatment of head and neck, liver, and lung cancers. Read More >>

Pages